Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Advances in improving cancer immunotherapy with nanotechnology: from smart nanoparticles to synergistic combination strategies
AuthorsUntack Cho; Jingjing Pu; Amit Sharma; Junhyuk Song; Ji Hyeon You; Yona Kim; Pyung Won Im; Hyung Woo Park; Hyo Eun Moon; Ho Sung Myeong; Hye Ran Park; Jian Hou; Ingo G. H. Schmidt-Wolf; Sun Ha Paek
Affiliations1. Department of Neurosurgery, Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Korea; 2. Department of Life and Chemical Engineering, Gyeonggi University of Science and Technology, Siheung, Korea; 3. Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 4. Department of Integrated Oncology, Center for Integrated Oncology (CIO) Bonn, University Hospital Bonn, Bonn, Germany; 5. Department of Neurosurgery, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea; 6. Advanced Institute of Convergence Technology, Seoul National University, Suwon, Korea
Mutation-specific dynamics of dedifferentiation trajectories and tumor–stromal interactions in thyroid cancer
AuthorsEun Hye Joo; Young Shin Song; Han Sai Lee; Gyeongseo Jung; Eun-jae Chung; Su-jin Kim; Yoo Hyung Kim; Sun Wook Cho; Hongyoon Choi; Jae-kyung Won; Woong-Yang Park; Young Joo Park
Affiliations1. Genomic Medicine Institute Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea; 2. Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea; 3. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; 4. Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea; 5. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; 6. Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea; 7. Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea; 8. Department of Surgery, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea; 9. Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; 10. Department of Pathology, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea; 11. Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea
Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer
AuthorsChunbo He; Dezhen Wang; Tuo Hu; Daisy Gonzalez; Ravi Thakur; Damian P. Matysniak; Ryan J. King; Sai Sundeep Kollala; Spas Dimitrov Markov; Yuki Fujii; Gullanki Naga Venkata Charan Tej; Junzhang Zhao; Longyang Jin; Rebecca Oberley-Deegan; Surendra K. Shukla; Xin A. Zhang; Jacob E. Friedman; Pankaj K. Singh; Michael A. Hollingsworth; Marina Pasca di Magliano; Howard C. Crawford; Kamiya Mehla
Affiliations1. Department of Oncology Science, University of Oklahoma Health Campus, Oklahoma City, USA; 2. Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, USA; 3. Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, USA; 4. OU Health Stephenson Cancer Center, University of Oklahoma Health Campus, Oklahoma City, USA; 5. Department of Biochemistry and Physiology, University of Oklahoma Health Campus, Oklahoma City, USA; 6. Harold Hamm Diabetes Center, University of Oklahoma Health Campus, Oklahoma City, USA; 7. Department of Surgery, University of Michigan, Ann Arbor, USA; 8. Department of Pharmacology and Toxicology, Michigan State University, Lansing, USA; 9. Department of Surgery, Henry Ford Health System, Detroit, USA; 10. Department of Microbiology and Immunology, University of Oklahoma Health Campus, Oklahoma City, USA; 11. Department of Pathology, University of Oklahoma Health Campus, Oklahoma City, USA
IL-17–driven tumor cell–intrinsic inflammatory programming creates an immunotherapy-permissive microenvironment
AuthorsKosuke Murakami; Shiki Takamura; Chiho Miyagawa; Shiro Takamatsu; Yoko Kashima; Koji Nagaoka; Yukari Kobayashi; Yoshiyuki Hakata; Shigeki Kato; Sachiyo Tsuji-Kawahara; Ding Nan; Ronald Chandler; Satoru Takahashi; Masaaki Miyazawa; Kazuhiro Kakimi; Noriomi Matsumura
Affiliations1. Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Sakai, Japan; 2. Laboratory for Immunological Memory, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; 3. Department of Immunology, Kindai University Faculty of Medicine, Sakai, Japan; 4. Department of Arts and Sciences, Kindai University Faculty of Medicine, Sakai, Japan; 5. Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, East Lansing, USA; 6. Department of Anatomy and Embryology and Laboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
Deconstructing cancer in 3D: models, mechanisms, and personalized solutions
AuthorsZhao Huang; Xirui Duan; Jun Ji; Qu Cai; Ping Jin; Beiqin Yu; Jun Zhang
Affiliations1. West China Institute of Preventive and Medical Integration for Major Diseases, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China; 2. Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 3. Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 4. State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan and Key Laboratory of Industrial Microbial Fermentation Engineering of Yunnan Province, School of Life Sciences, Yunnan University, Kunming, China; 5. Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 6. Shanghai Key Laboratory of Gastric Neoplasms, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Insight of immune checkpoint blockades in melanoma: mechanism and clinical translation
AuthorsQingyan Zhang; Chunhui Yuan; Lin Zhu; Shaobing Zheng; Yantao Xu; Xuanlin Che; Shiyu Xiao; Juan Liu; Hong Liu; Hui Li; Xiang Chen
Affiliations1. The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China; 2. National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Central South University, Changsha, China; 3. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China; 4. Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; 5. National Medical Metabolomics International Collaborative Research Center, Xiangya Hospital, Central South University, Changsha, China; 6. Furong Laboratory, Changsha, China; 7. Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China
Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation
AuthorsJunzhi Liu; Xiaoyu Zuo; Xue Yang; Xinyue Wang; Lu Gan; Jianxin Xue
Affiliations1. Division of Thoracic Tumour Multimodality Treatment, Cancer Center & State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China; 2. Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China; 3. Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China; 4. Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China; 5. Laboratory of Clinical Cell Therapy, West China Hospital, Sichuan University, Chengdu, China
Histone modifications across cancers: mechanisms, therapy and clinical translation
AuthorsPengde Lu; Yau-Tuen Chan; Chun-Fung Kwok; Qiucheng Li; Zhuofeng Jiang; Lin Xu; Zixin Feng; Hongchao Yuan; Jiaqi Zou; Yunqing Xun; Tung-Leong Fong; Chi-Ming Che; Ning Wang
Affiliations1. School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong S.A.R.,, P. R. China; 2. State Key Laboratory of Synthetic Chemistry, Department of Chemistry, The University of Hong Kong, Hong Kong, China; 3. Laboratory for Synthetic Chemistry and Chemical Biology Limited, Hong Kong Science Park, Hong Kong
Navigating luminal heterogeneity: etiology-based proteogenomic subtyping for targeted treatment strategies in breast cancer
AuthorsYa-Hsuan Chang; Yi-Ju Chen; Zhi-Jie Hong; Yi-Jing Hsiao; Kuen-Tyng Lin; Guo-Shiou Liao; Sheng-Fang Su; Ze-Shiang Lin; Huei-Wen Chen; Chia-Li Han; Eric Sheng-Wen Chen; Yin-Chen Hsu; Yan-Ming Chen; Hao Fang; Hao-Chin Yang; Yan-Si Chen; Chien-Yu Lin; Hsiang-En Hsu; Ching-Hung Lin; Pin-Lian Jiang; Pei-Shan Wu; Ching-Wen Chen; Chen-Ting Hung; Ethan Wu; Wei-Tzu Chiu; Fan-Ni Hsing; Tsai-Pei Liu; Chia-Yu Wang; Yu-Tai Wang; Chang-Wei Yeh; Ki-Hok Liao; Ana I Robles; Henry Rodriguez; Show-Ling Yang; Mien-Chie Hung; Yen-Shen Lu; Hsuan-Yu Chen; Sung-Liang Yu; Jyh-Cherng Yu; Yu-Ju Chen
Affiliations1. Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan; 2. Institute of Statistical Science, Academia Sinica, Taipei, Taiwan; 3. Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; 4. Institute of Chemistry, Academia Sinica, Taipei, Taiwan; 5. Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan; 6. Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan; 7. Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan; 8. Graduate Institute of Toxicology, National Taiwan University College of Medicine, Taipei, Taiwan; 9. Master Program in Clinical Genomics and Proteomics, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; 10. Department of Medical Oncology, Cancer Center Branch, National Taiwan University Hospital, Taipei, Taiwan; 11. Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; 12. Department of Chemistry, National Taiwan University, Taipei, Taiwan; 13. National Center for High-performance Computing, National Institutes of Applied Research, Hsinchu, Taiwan; 14. Office of Cancer Clinical Proteomics Research, National Cancer Institute, National Institutes of Health, Rockville, USA; 15. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; 16. Graduate Institute of Biomedical Sciences, Cancer Biology and Precision Therapeutics Center, Center for Molecular Medicine, China Medical University, Taichung, Taiwan; 17. Ph.D. Program in Microbial Genomics, National Chung Hsing University, Taichung, Taiwan; 18. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma
AuthorsFanhong Zeng; Jiaxin Guo; Zheng Zeng; Vanilla Xin Zhang; Yu-Man Tsui; Po-Man Li; Abdullah Husain; Qingyang Zhang; Joyce Man-Fong Lee; Tan-To Cheung; Daniel Wai-Hung Ho; Irene Oi-Lin Ng
Affiliations1. Department of Pathology, The University of Hong Kong, Hong Kong, China; 2. State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China; 3. Department of Surgery, The University of Hong Kong, Hong Kong, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
